Titan Pharmaceuticals
TTNP
#10403
Rank
HK$47.69 M
Marketcap
HK$35.85
Share price
-3.76%
Change (1 day)
42.36%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.14. In 2023 the company made an earnings per share (EPS) of -HK$57.63 an increase over its 2022 EPS that were of -HK$118.13.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$57.63-51.22%
2022-HK$118.13-15.61%
2021-HK$139.98-81.37%
2020-HK$751.24-77.52%
2019-HK$3,342-56.32%
2018-HK$7,652-59.51%
2017-HK$18,902-371.81%
2016HK$6,954-144.35%
2015-HK$15,678300%
2014-HK$3,920-121.54%
2013HK$18,198-151.38%
2012-HK$35,416-11.54%
2011-HK$40,035188.89%
2010-HK$13,858-10%
2009-HK$15,398
2007-HK$63,133-2.38%
2006-HK$64,673-39.13%
2005-HK$106,248-16.87%
2004-HK$127,805-22.43%
2003-HK$164,7614.9%
2002-HK$157,06261.9%
2001-HK$97,009-13.7%
2000-HK$112,40765.01%
1999-HK$68,123-35.87%
1998-HK$106,230-1824.71%
1997HK$6,159-102.4%
1996-HK$257,151

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-HK$11.04-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.94-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.29-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.19-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.24-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
HK$0.23-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA